These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 30165194)
1. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Huang Y; Xiang B; Liu Y; Wang Y; Kan H Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194 [TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
4. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1. Dong H; Jian P; Yu M; Wang L J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261 [TBL] [Abstract][Full Text] [Related]
8. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway. Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185 [TBL] [Abstract][Full Text] [Related]
12. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
13. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161 [TBL] [Abstract][Full Text] [Related]
14. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558 [TBL] [Abstract][Full Text] [Related]
15. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Zhou Y; Huang Y; Dai T; Hua Z; Xu J; Lin Y; Han L; Yue X; Ho L; Lu J; Ai X Biomed Pharmacother; 2021 Jan; 133():111030. PubMed ID: 33378944 [TBL] [Abstract][Full Text] [Related]
16. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
17. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis. Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing Ai J; Sun J; Zhou G; Zhu T; Jing L Cell Cycle; 2020 Apr; 19(7):742-757. PubMed ID: 32089066 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
20. LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma. Zhang K; Zhao Z; Yu J; Chen W; Xu Q; Chen L J Cell Biochem; 2018 Jul; 119(7):6045-6056. PubMed ID: 29574975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]